Docket Management
Docket: 00D-1538 - Draft Guidance for Industry; Electronic Records; Electronic Signatures, Validation
Comment Number: EC -3

Accepted - Volume 6

Comment Record
Commentor Mr. Wolfgang Winter Date/Time 2001-12-21 09:08:01
Organization Agilent Technologies Deutschland GmbH
Category Company

Comments for FDA General
Questions
1. General Comments Section 5.4.3 How test results should be expressed Discussion: The paragraph does not adequately reflect that test cases and test results must be documented together. The requirement for quantitive vs. qualitative test results is stated in an ambiguous way. Qualitative (pass/fail) information is important to document and review test status and progress during the validation phase. A test result has to be either pass or fail based on the quantitative measurements obtained during execution of the associated test case and the acceptance limits. Recommendation: Reword the paragraph to state Quantifiable test results should be recorded using the measured, quantitative result, the acceptance criteria as well as a qualitative result such as Pass/Fail information.




EC -3